Chiltern to Acquire Theorem Clinical Research
Chiltern, a global CRO headquartered in the UK, announced it has signed a purchase agreement to acquire Theorem Clinical Research, based in Wilmington, NC. The combined company will operate under the name Chiltern and will gain global reach - most notably in China and Japan - as well as new service offerings for medical devices and diagnostics, clinical analytics and clinical supplies. The transaction is expected to close within the next several weeks.
Chiltern, a global CRO headquartered in the UK, announced it has signed a purchase agreement to acquire Theorem Clinical Research, based in Wilmington, NC.
The combined company will operate under the name Chiltern and will gain global reach - most notably in China and Japan - as well as new service offerings for medical devices and diagnostics, clinical analytics and clinical supplies. The transaction is expected to close within the next several weeks.
Read the full release.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
